Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Baricitinib (LY3009104) in Participants With COVID-19

ClinicalTrials.gov ID: NCT04421027

Public ClinicalTrials.gov record NCT04421027. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 3:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The reason for this study is to see if the study drug baricitinib is effective in hospitalized participants with COVID-19.

Study identification

NCT ID
NCT04421027
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,525 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 11, 2020
Primary completion
Feb 11, 2021
Completion
Jun 9, 2021
Last update posted
Jul 27, 2022

2020 – 2021

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Dignity Health Mercy Gilbert Medical Center Gilbert Arizona 85297
Valleywise Health Phoenix Arizona 85008
St Joseph's Hospital and Medical Center Phoenix Arizona 85013
Hoag Memorial Hospital Presbyterian Newport Beach California 92663
Sharp Memorial Hospital San Diego California 92123
San Francisco VA Medical Center San Francisco California 94121
Torrance Memorial Medical Center Torrance California 90505
Holy Cross Hospital Inc. Fort Lauderdale Florida 33308
Westchester General Hospital Miami Florida 33155
Grady Health System Atlanta Georgia 30303
Atlanta VA Medical Center Decatur Georgia 30033
Great Lakes Clinical Trials Chicago Illinois 60640
Parkview Regional Medical Center Fort Wayne Indiana 46845
Community Hospital South Indianapolis Indiana 46227
Franciscan St. Francis Health Indianapolis Indiana 46237
South Shore Hospital Weymouth Massachusetts 02190
Henry Ford Hospital Detroit Michigan 48202
Renown Regional Med. Center Reno Nevada 89502
SUNY Downstate Brooklyn New York 11203
East Carolina University Greenville North Carolina 27834
OSU Med Intl Med Houston Ctr Tulsa Oklahoma 74127
Oregon Health and Science University Portland Oregon 97239
Temple Univ School of Med Philadelphia Pennsylvania 19140
Swedish Medical Center Seattle Washington 98104
MultiCare Good Samaritan Hospital Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04421027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2022 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04421027 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →